Kadinda kronik ağrili mesane sendromu ve interstisyel siSTİte bağli ağri tanim

70- Hanno PM, Landis JR, Matthews-Cook Y, Kusek J, Nyberg L. The diagnosis of interstitial cystitis revisited: lessons learned from the national institutes of health interstitial cystitis database study. J Urol 161: 553-557, 1999.

71- Waxman JA, Sulac PJ, Kuehl TJ. Cystoscopic findings consistent with interstitial cystitis in normal women undergoing tubal ligation. J Urol 160: 1663-1667, 1998.

72- Erickson DR. Glomerulations in women with urethral sphincter deficiency: Report of 2 cases. J Urol 153: 728-729, 1995.

73- Nordling J, Anjum FH, Bade JJ, Bouchelouche K, Bouchelouche P, Cervigni M, et al. Primary evaluation of patients suspected of having interstitial cystitis (IC). Eur Urol 45: 662-669, 2004.

74- Trachtenberg J, Roehrborn CG. Updated results of a randomized, double-blind, multicenter sham-controlled trial of microwave thermotherapy with the dornier urowave in patients with symptomatic benign prostatic hyperplasia. Urowave Investigators Group. World J Urol 16: 102-108, 1998.

75- Peeker R, Fall M. Toward a precise definition of interstitial cystitis: further evidence of differences in classic and nonulcer disease. J Urol 167: 2470-2472, 2002.

76- Keay S, Zhang CO, Trifillis AL, Hise MK, Hebel JR, Jacobs SC, et al. Decreased 3H-thymidine incorporation by human bladder epithelial cells following exposure to urine from interstitial cystitis patients. J Urol 156: 2073-2078, 1996.

77- Keay S, Zhang CO, Hise MK, Hebel JR, Jacobs SC, Gordon D, et al. A diagnostic in vitro urine assay for interstitial cystitis. Urology 52: 974-978, 1998.

78- Byrne DS, Sedor JF, Estojak J. The Urinary glycoprotein GP-51 as a clinical marker for interstitial cystitis. J Urol 161: 1786-1790, 1999.

79- Lamale LM, Lutgendorf SK, Zimmerman MB, Kreder KJ. Interleukin-6, histamine, and methylhistamine as diagnostic markers for interstitial cystitis. Urology 68: 702-706, 2006.

80- Erickson DR, Xie SX, Bhavanandan VP, Wheeler MA, Hurst RE, Demers LM, et al. A comparison of multiple urine markers for interstitial cystitis. J Urol 167: 2461-2469, 2002.

81- Parsons CL, Koprowski PF. Interstitial cystitis: successful management by increasing urinary voiding intervals. Urology 37: 207-212, 1991.

82- Breau RH, Norman RW. The role of self-help groups in education and supporting patients with prostate cancer and interstitial cystitis. BJU Int 92: 602-606, 2003.

83- Whitmore KE. Complementary and alternative therapies as treatment approaches for interstitial cystitis. Reviews Urol 4: 28-35, 2002.

84- Moldwin RM, Sant GR. Interstitial cystitis: a pathophysiology and treatment update. Clin Obstet Gynecol 45: 259-272, 2002.

85- Lukban JC, Whitmore KE, Sant GR. Current management of interstitial cystitis. Urol Clin North Am 29: 649-660, 2002.

86- Sadhukhan PC, Tchetgen BM, Rackley RR. Sodium pentosan polysulfate reduces urothelial responses to inflammatory stimuli via an indirect mechanism. J Urol 168: 289-292, 2002.

87- Mulholland SG, Hanno P, Parsons CL, Sant GR, Staskin DR. Pentosan polysulfate sodium for therapy of interstitial cystitis. A doublblind placebo-controlled clinical study. Urology 35: 552-558, 1990.

88- Tura B, Tura SM. The analgesic effect of tricyclic antidepressants. Brain Res 518: 19-22, 1990.

89- Van Ophoven A, Pokupic S, Heinecke A, Hertle L. A prospective, randomized, placebo controlled, double-blind study of amitriptyline fort he treatment of interstitial cystitis. J Urol 172: 533-536, 2004.

90- Theoharides TC. Hydroxyzine in the treatment of interstitial cystitis. Urol Clin North Am 21: 113-119, 1994.

91- Theoharides TC, Sant GR. Hydroxyzine therapy for interstitial cystitis. Urology 49: 108-110, 1997.

92- Sant GR, Propert KJ, Hanno PM, Burks D, Culkin D, Diokno AC, et al. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol 170: 810-815, 2003.

93- Thilagarajah R, Witherow RO, Walker MM. Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial. BJU Int 87: 207-212, 2001.

94- Ueda T, Tamaki M, Ogawa O, Yamauchi T, Yoshimura N. Improvement of interstitial cystitis symptoms and problems that developed during treatment with oral IPD-1151T. J Urol 164: 1917-1920, 2000.

95- Fall M, Oberpenning F, Peeker R. Treatment of bladder pain syndrome/interstitial cystitis 2008: Can we make evidence-based decisions? Eur Urol 54: 65-78, 2008.

96- Hanno P, Lin A, Nordling J, Nyberg L, Van Ophoven A, Ueda T, et al. Bladder pain syndrome international consultation on incontinence. Neurourol Urodyn 29: 191-198, 2010.

97- Sant GR, LaRock DR. Standard intravesical therapies for interstitial cystitis. Urol Clin North Am 21: 73-83, 1994.

98- Asklin B, Cassuto J. Intravesical lidocaine in severe interstitial cystitis. Case report. Scand J Urol Nephrol 23: 311-312, 1989.

99- Parsons CL. Successful downregulation of bladder sensory nerves with combination of heparin and alkanized lidocaine in patients with interstitial cystitis. Urology 65: 45-48, 2005.

100- Rossberger J, Fall M, Peeker R. Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis: discomfort, side-effects and treatment outcome. Scand J Urol Nephrol 39: 73-77, 2005.

101- Bade JJ, Laseur M, Nieuwenburg A, Van Der Weele LT, Mensink HJ. A placebo-controlled study of intravesical pentosanpolysulphate fort he treatment of interstitial cystitis. Br J Urol 79: 168-171, 1997.

102- Parsons CL, Housley T, Schmidt JD, Lebow D. Treatment of interstitial cystitis with intravesical heparin. Br J Urol 73: 504-507, 1994.

103- Kuo HC. Urodynamic results of intravesical heparin therapy for women with frequency urgency syndrome and interstitial cystitis. J Formos Med Assoc 100: 309-314, 2001.

104- Morales A, Emerson L, Nickel JC, Lundie M. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol 156: 45-48, 1996.

105- Shao Y, Shen ZJ, Rui WB, Zhou WL. Intravesical instillation of hyaluronic acid prolonged the effect of bladder hydrodistention in patients with severe interstitial cystitis. Urology 75: 547-550, 2010.

106- Steinhoff G. The efficacy of chondroitin sulfate in treating interstitial cystitis. Eur Urol 2: 14-16, 2003.

107- Lazeri M, Beneforti P, Spinelli M, Zanollo A, Barbagli G, Turini D. Intravesical resiniferatoxin fort he treatment of hypersensitive disorder: a randomized placebo controlled study. J Urol 164: 676-679, 2000.

108- Payne CK, Mosbaugh PG, Forrest JB, Evans RJ, Whitmore KE, Antoci JP, et al. Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. J Urol 173: 1590-1594, 2005.

109- Smith CP, Radziszewski P, Borkowski A, Somogyi GT, Bone TB, Chancellor MB. Botulinum toxin A has antinociceptive effects in treating interstitial cystitis. Urology 64: 871-875, 2004.

110- Giannantoni A, Costantini E, Di Stasi SM, Tascini MC, Bini V, Porena M. Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: A pilot study. Eur Urol 49: 704-709, 2006.

111- Perez-Marrero R, Emerson LE, Feltis JT. A controlled study of dimethyl sulfoxide in interstitial cystitis. J Urol 140: 36-39, 1988.

112- Badenoch AW. Chronic interstitial cystitis. Br J Urol 43: 718-721, 1971.

113- Chai TC, Ahang CO, Shoenfelt JL. Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis. J Urol 163: 1440-1444, 2000.

114- Van Ophoven A, Rossbach G, Oberpenning F, Hertle L. Hyperbaric oxygen for the treatment of interstitial cystitis: long-term results of a prospective pilot study. Eur Urol 46: 108-113, 2004.

115- Peters KM, Carey JM, Konstandt DB. Sacral neuromodulation for the treatment of refractory interstitial cystitis: outcomes based on technique. Int Urogynecol J Pelvic Floor Dysfunct 14: 223-228, 2003.

116- Comiter CV. Sacral neuromodulation fort he symptomatic treatment of refractory interstitial cystitis: a prospective study. J Urol 169: 1369-1373, 2003.

117- Zabihi N, Mourtzinos A, Maher MG, Raz S, Rodriguez LV. Short-term results of bilateral S2-S4 sacral neuromodulation for the treatment of refractory interstitial cystitis, painful bladder syndrome, and chronic pelvic pain. Int Urogynecol J Pelvic Floor Dysfunct 19: 553-557, 2008.

118- Peters KM, Killinger KA, Bogulawski BM, Boura JA. Chronic pudental neuromodulation: Expanding available treatment options for refractory urologic symptoms. Neurourol Urodyn 28: Epub ahead of print, 2009

119- Rosamilia A, Dwyer PL, Gibson J. Electromotive drug administration of lidocaine and dexamethasone followed by cystudistention in women with interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct, 8: 142-145, 1997.

120- Riedl CR, Knoll M, Plas E, Pfluger H. Electromotive drug administration and hydrodistention for the treatment of interstitial cystitis. J Endourol 12: 269-272, 1998.

121- Geirsson G, Wang YH, Lindstrom S, Fall M. Traditional acupuncture and electrical stimulation of the posterior tibial nevre. A trial in chronic interstitial cystitis. Scand J Urol Nephrol 27: 67-70, 1993.

122- Lynch DF Jr. Empowering the patient: hypnosis in the management of cancer, surgical disease and chronic pain. Am J Clin Hypn 42: 122-130, 1999.